EMAIL DETAILS
SUBJECT:
Eye on the Market, January 11, 2012
PRI: NORMAL
FROM:
C
christopher.w.mason@jpmorgan.com
DATE:
2012-01-11 23:01:51
MSG_ID:
<31A196CCF5023344AFE6650D361CE7FC01F812@SCACMX002.exchad.jpmchase.net>
RECIPIENTS:
TO:
C
Mason, Christopher W
<christopher.w.mason@jpmorgan.com>
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
Eye on the Market, January 11, 2012
Postscripts on our portfolios; credit investing; S&P earnings; equity manager alpha; and Europe/Italy/UniCredito
Last week we published our Outlook for 2012. The latest data confirm some of the trends highlighted in the piece:
** Better economic data in the US (fueled by an expansion in consumer credit and a modestly better labor report, even after accounting for an anomaly in courier payrolls), but no progress on long-term fiscal consolidation
** Slowing growth in China, rising hopes for easier monetary policy as inflation crests, and government "encouragement" for Chinese pension funds, insurance companies, national endowment funds and housing funds to buy more Chinese equities. We will focus in greater detail on the implications of the China slowdown in a future note.
** Weakness in Europe, the severity of which is mitigated by the ever-expanding European Central Bank (Gargantua) and US dollar swap lines from the Federal Reserve (Pantagruel)
This week, some follow-ups to the 2012 Outlook, with a focus on portfolios and markets.
Portfolio positioning. Given our view that growth will be below trend in the US (and elsewhere), our portfolios are designed to reflect that. In the first chart, we break down returns on equities, high yield and hedge funds in different growth environments since 1989. It would have been better to have more history here, but hedge fund and credit market returns before 1989 are not reliable proxies for investment results. Since 1989, during 0%-3% growth periods, returns were similar for all three categories. There is considerable dispersion within each bar (shown by the standard deviation of each bar's returns). Equities have the highest return dispersion, but are often more tax-efficient than either credit or hedge funds, so all of that is baked into our portfolio allocations. We now hold a bit more credit and hedge funds and less equities than usual, for reasons explained above, and in the 2012 Outlook. Within equities, our positions are overweight the US. The sum of all three categories (public and private equity, high yield and hedge funds) ranges from 60% to 70% in our Balanced model portfolios across jurisdictions.
[cid:image009.png@01CCD083.A66B8820]
Credit investing: distressed debt vs. high-coupon "mezzanine" lending. Does distressed debt investing still make sense? Right now, there's not as much distress as in 2008-2009, at least when measured by prices on non-defaulted high yield bonds and leveraged loans (see chart). Only 10% of the HY and loan markets are priced below 80 cents on the dollar. Even so, our distressed debt managers refer to ample opportunities: 10 percent of a $2 trillion combined HY/loan market is still $200 billion to choose from. That is perhaps why their average position prices range from 65 to 75 cents on the dollar. But to me, it seems axiomatic that the sweet spot for distressed debt is when markets are emerging from recession; that's why distressed debt had its best years (relative and absolute) in 2003-2004 and 2009-2010. For that reason, we consider private lending an interesting complement. The chart on the right shows the number of bond issues from mid-market firms (defined as those with less than 50 million in annual cash flow before interest, taxes and depreciation). While debt markets are receptive to issuance from large well-known companies, mid-market companies are no longer welcomed as they were during the last two bull credit markets. This is what creates the opportunity for high-coupon private lending, a strategy we outlined in the 2012 Outlook in chart c62. Our current exposures are roughly 2-1 in favor of mezzanine lending over distressed debt.
[cid:image010.png@01CCD083.A66B8820]
Earnings. Wall Street sometimes has a habit of saying that good news is good news, and that bad news is also good news. Case in point: in Q4 2011, companies reporting prior to Alcoa ended their streak of beating consensus earnings (first chart), and at the same time, there was a sharp rise in negative pre-announcements (second chart). However, many equity research reports point out that over the last decade, S&P 500 performance in quarters that follow rising negative pre-announcements have been pretty good (see table), perhaps due to resetting of earnings expectations that companies then beat. I am not sure that this theory is any more robust than the "year 3 of the Presidential cycle is a good one for the S&P" that failed last year. Either way, we are penciling in 2012 S&P profits at $102-$104 for 2012, which when superimposed on 12x-13x multiples, results in expectations of a single-digit return year. History has a habit of defying single-digit return expectations in both directions (see third chart below), but that's what things look like to us right now.
[cid:image011.png@01CCD083.A66B8820]
[cid:image012.png@01CCD083.A66B8820]
Equity manager performance. 2011 was a difficult one for many active equity managers. As shown in the table on the following page, stock dispersion within S&P 500 sectors was lower than average, and in the case of the shaded sectors (consumer discretionary, staples, industrials, materials and utilities), dispersions were close to the lowest levels of the last 20 years. With lower stock dispersions, opportunities for active managers shrink. That's what is shown in the second chart, which plots the average dispersion of stocks within the S&P 500 alongside the percentage of Large Cap Core managers beating their benchmarks. The relationship is not air tight; in 2005, managers did a better job despite low levels of stock dispersion.
The key question here is whether there is a structural decline in the potential for equity manager alpha. There are reasons to wonder whether Reg FD disclosure requirements (imposed in 2000), the advent of exchange-traded funds, high-frequency trading robots and other technical changes have changed the landscape for active equity managers. However, the industry has been through a similar trough in the mid-1990s, and rebounded. The unique circumstances of 2011 (first US ratings downgrade in 100 years, unraveling of the European Monetary Union, etc.) argue against making too many inferences from what was a very difficult year for active management in 2011. This year is an important one for the industry to regain momentum.
[cid:image014.png@01CCD083.A66B8820]
The latest from Europe: strange days
There are bizarre things happening in Europe. A proxy for intra-European capital flight and monetary conditions (first chart) shows an implosion in the Periphery, and a rise in the Core. Meanwhile, like Rabelais' Gargantua, the ECB balance sheet continues to rise (second chart). So far, European banks don't seem inclined to increase government bond exposure like they did after the first round of longer-term ECB repo facilities were announced in 2009 (third chart). Were it not for the ECB, countries like Italy and Spain would probably have left the Euro already, given what is going on with domestic credit and capital flows. Is this good news? If this process allows time for Italy and Spain to morph into Mediterranean versions of Germany, then yes. But if all this is doing is shifting eventual losses from the private sector to the ECB, I'm not as sure.
[cid:image016.png@01CCD083.A66B8820]
[cid:image018.png@01CCD083.A66B8820]
As for capital raises by EU banks, UniCredito sends a tough message in terms of what it might take. The math gets tricky here, since companies usually do not engage in secondary offerings that amount to 60% of their entire market cap. UniCredito's stock price collapsed after their rights offering was announced, but some of this is to be expected given the dilution to existing shareholders. Here's how we see it: the stock traded at 6.33 on the close of January 3rd, the day before the rights announcement. Given the number of existing shares, the new shares issued in the rights offering, the market cap on January 3rd and the new capital raised, the stock should have declined to 3.40 (the "theoretical ex-rights price", or TERP), assuming no change in the company's outlook, and just based on the mathematical dilution. The rights price offered to existing shareholders of 1.94 looked attractive, at a 43% discount to the TERP. What was interesting to us: what reward would UniCredito get from the markets for reducing perceived insolvency risk, and how stable was the 43% discount offered to existing shareholders.
Now that UniCredito's share price reflects its capital raise, we can evaluate both questions. On the first point, the stock price has fallen to 2.57 (see below), below the level that would have been predicted simply by the amount of dilution. Some of this may be a consequence of a massively in-the-money rights price putting downward pressure on the stock; if so, it may be premature to draw too many conclusions. Even so, it does not look like the markets are giving UniCredito much credit for raising 7.5 billion Euros. [In contrast, consider the stock price reaction shown below to Regions Bank in 2009, when it also raised equity equal to 60% of its pre-deal market cap]. The UniCredito outcome is unsurprising, given their 35-40 bn Euros of exposure to Italian government bonds. On the second point, what looked like a 43% discount for existing shareholders has fallen to 20%, with another two weeks to go before the rights offering period ends.
The bottom line here is that the reward required for underwriters and investors to recapitalize European banks is very high, and potentially destabilizing on its own. This is likely to be the case until risks surrounding sovereign debt are resolved.
[cid:image020.png@01CCD083.A66B8820]
Michael Cembalest
Chief Investment Officer
The material contained herein is intended as a general market commentary. Opinions expressed herein are those of Michael Cembalest and may differ from those of other J.P. Morgan employees and affiliates. This information in no way constitutes J.P. Morgan research and should not be treated as such. Further, the views expressed herein may differ from that contained in J.P. Morgan research reports. The above summary/prices/quotes/statistics have been obtained from sources deemed to be reliable, but we do not guarantee their accuracy or completeness, any yield referenced is indicative and subject to change. Past performance is not a guarantee of future results. References to the performance or character of our portfolios generally refer to our Balanced Model Portfolios constructed by J.P. Morgan. It is a proxy for client performance and may not represent actual transactions or investments in client accounts. The model portfolio can be implemented across brokerage or managed accounts depending on the unique objectives of each client and is serviced through distinct legal entities licensed for specific activities. Bank, trust and investment management services are provided by J.P. Morgan Chase Bank, N.A, and its affiliates. Securities are offered through J.P. Morgan Securities LLC (JPMS), Member NYSE, FINRA and SIPC. Securities products purchased or sold through JPMS are not insured by the Federal Deposit Insurance Corporation ("FDIC"); are not deposits or other obligations of its bank or thrift affiliates and are not guaranteed by its bank or thrift affiliates; and are subject to investment risks, including possible loss of the principal invested. Not all investment ideas referenced are suitable for all investors. Speak with your J.P. Morgan Representative concerning your personal situation. This material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. Private Investments may engage in leveraging and other speculative practices that may increase the risk of investment loss, can be highly illiquid, are not required to provide periodic pricing or valuations to investors and may involve complex tax structures and delays in distributing important tax information. Typically such investment ideas can only be offered to suitable investors through a confidential offering memorandum which fully describes all terms, conditions, and risks.
IRS Circular 230 Disclosure: JPMorgan Chase & Co. and its affiliates do not provide tax advice. Accordingly, any discussion of U.S. tax matters contained herein (including any attachments) is not intended or written to be used, and cannot be used, in connection with the promotion, marketing or recommendation by anyone unaffiliated with JPMorgan Chase & Co. of any of the matters addressed herein or for the purpose of avoiding U.S. tax-related penalties. Note that J.P. Morgan is not a licensed insurance provider. (c) 2012 JPMorgan Chase & Co; All rights reserved
This email is confidential and subject to important disclaimers and
conditions including on offers for the purchase or sale of
securities, accuracy and completeness of information, viruses,
confidentiality, legal privilege, and legal entity disclaimers,
available at http://www.jpmorgan.com/pages/disclosures/email.
METADATA:
THREAD:
TOPIC:
Eye on the Market, January 11, 2012
INDEX:
AczQrY+gWpNvjoVQRyGJkFwWhwuRwwAAWQDwAACjLSAAADk5QAAAOCiAAAAbjKAAAETWMA==